269 related articles for article (PubMed ID: 14599084)
1. Molecular neuro-oncology and development of targeted therapeutic strategies for brain tumors. Part 1: Growth factor and Ras signaling pathways.
Newton HB
Expert Rev Anticancer Ther; 2003 Oct; 3(5):595-614. PubMed ID: 14599084
[TBL] [Abstract][Full Text] [Related]
2. Small-molecule and antibody approaches to molecular chemotherapy of primary brain tumors.
Newton HB
Curr Opin Investig Drugs; 2007 Dec; 8(12):1009-21. PubMed ID: 18058572
[TBL] [Abstract][Full Text] [Related]
3. Molecular neuro-oncology and the development of targeted therapeutic strategies for brain tumors. Part 5: apoptosis and cell cycle.
Newton HB
Expert Rev Anticancer Ther; 2005 Apr; 5(2):355-78. PubMed ID: 15877531
[TBL] [Abstract][Full Text] [Related]
4. Molecular neuro-oncology and the development of targeted therapeutic strategies for brain tumors. Part 4: p53 signaling pathway.
Newton HB
Expert Rev Anticancer Ther; 2005 Feb; 5(1):177-91. PubMed ID: 15757449
[TBL] [Abstract][Full Text] [Related]
5. Molecular neuro-oncology and the development of targeted therapeutic strategies for brain tumors. Part 3: brain tumor invasiveness.
Newton HB
Expert Rev Anticancer Ther; 2004 Oct; 4(5):803-21. PubMed ID: 15485315
[TBL] [Abstract][Full Text] [Related]
6. Growth factors as active participants in carcinogenesis: a perspective.
Halper J
Vet Pathol; 2010 Jan; 47(1):77-97. PubMed ID: 20080487
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy for glioblastoma: current treatment and future perspectives for cytotoxic and targeted agents.
Minniti G; Muni R; Lanzetta G; Marchetti P; Enrici RM
Anticancer Res; 2009 Dec; 29(12):5171-84. PubMed ID: 20044633
[TBL] [Abstract][Full Text] [Related]
8. Treatment of malignant gliomas: radiotherapy, chemotherapy and integration of new targeted agents.
Nieder C; Grosu AL; Mehta MP; Andratschke N; Molls M
Expert Rev Neurother; 2004 Jul; 4(4):691-703. PubMed ID: 15853588
[TBL] [Abstract][Full Text] [Related]
9. Signaling pathways in pancreatic cancer.
Reddy SA
Cancer J; 2001; 7(4):274-86. PubMed ID: 11561604
[TBL] [Abstract][Full Text] [Related]
10. New treatment strategies for malignant gliomas.
Sathornsumetee S; Rich JN
Expert Rev Anticancer Ther; 2006 Jul; 6(7):1087-104. PubMed ID: 16831080
[TBL] [Abstract][Full Text] [Related]
11. Growth factors and their receptors in metastasis.
Radinsky R
Semin Cancer Biol; 1991 Jun; 2(3):169-77. PubMed ID: 1655117
[TBL] [Abstract][Full Text] [Related]
12. Molecular neuro-oncology and development of targeted therapeutic strategies for brain tumors. Part 2: PI3K/Akt/PTEN, mTOR, SHH/PTCH and angiogenesis.
Newton HB
Expert Rev Anticancer Ther; 2004 Feb; 4(1):105-28. PubMed ID: 14748662
[TBL] [Abstract][Full Text] [Related]
13. [Microbiological approach to the treatment of brain tumors].
Kuratsu J; Ushio Y
Gan To Kagaku Ryoho; 1991 Feb; 18(2):195-200. PubMed ID: 1992913
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms of signal transduction: epidermal growth factor receptor family, vascular endothelial growth factor family, Kit, platelet-derived growth factor receptor, Ras.
Erman M
J BUON; 2007 Sep; 12 Suppl 1():S83-94. PubMed ID: 17935283
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor receptor autocrine signaling in RIE-1 cells transformed by the Ras oncogene enhances radiation resistance.
Grana TM; Sartor CI; Cox AD
Cancer Res; 2003 Nov; 63(22):7807-14. PubMed ID: 14633707
[TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor receptor inhibitors in neuro-oncology: hopes and disappointments.
Brandes AA; Franceschi E; Tosoni A; Hegi ME; Stupp R
Clin Cancer Res; 2008 Feb; 14(4):957-60. PubMed ID: 18281526
[TBL] [Abstract][Full Text] [Related]
17. Molecularly targeted therapy for malignant glioma.
Sathornsumetee S; Reardon DA; Desjardins A; Quinn JA; Vredenburgh JJ; Rich JN
Cancer; 2007 Jul; 110(1):13-24. PubMed ID: 17520692
[TBL] [Abstract][Full Text] [Related]
18. Growth factors and their action in vivo and in vitro.
Gospodarowicz D
J Pathol; 1983 Nov; 141(3):201-33. PubMed ID: 6319652
[TBL] [Abstract][Full Text] [Related]
19. Understanding the predictive role of K-ras for epidermal growth factor receptor-targeted therapies in colorectal cancer.
Ramos FJ; Macarulla T; Capdevila J; Elez E; Tabernero J
Clin Colorectal Cancer; 2008 Dec; 7 Suppl 2():S52-7. PubMed ID: 19064407
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor type I biology and targeting in malignant gliomas.
Trojan J; Cloix JF; Ardourel MY; Chatel M; Anthony DD
Neuroscience; 2007 Mar; 145(3):795-811. PubMed ID: 17320297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]